The Medication(s) listed below have been approved by the Food & Drug Administration (FDA) as orphan products for treatment of this condition. There may be other products available
that are not considered orphan products.
Telotristat etiprate (Brand name: Xermelo)
- Manufactured by
Lexicon Pharmaceuticals, Inc
FDA-approved indication: Treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy.
National Library of Medicine Drug Information Portal